Overall, these results suggest that IKBIP expression is correlated with TMB, MSI, ICGs, and TME in multiple pan-cancer datasets, convincingly indicating that it could be a robust and reliable biomarker for predicting the responses of cancer cells to immunotherapy. Here, IKBIP is linked to cancer.